Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 59,152 shares at $75.73 ($4.5M) on 2020-08-24, disclosed to the SEC on 2020-08-25.
Open-market sale of $4.5M HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.73 | 27,753 | $2.1M | 46.9% |
| 2 | $75.73 | 27,753 | $2.1M | 46.9% |
| 3 | $76.23 | 1,823 | $139K | 3.1% |
| 4 | $76.23 | 1,823 | $139K | 3.1% |
| Total | $75.76 avg | 59,152 | $4.5M | 100% |
| Filing → |
| HZNP | SELL | 2022-03-25 | $5.7M | — | Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |